AVICANNA INC.

Profile

Company Names

AVICANNA INC.

Addresses

480 UNIVERSITY AVENUE, SUITE 1502, TORONTO, A6 M5G 1V2

Phone Numbers

647.243.5283

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

ONTARIO, CANADA

Total Amount Raised:

$10,003,980.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-08-17 
$2,039,427.00 
$2,039,427.00 
$0.00 
Equity 
5
2022-05-06 
$1,099,939.00 
$2,087,936.00 
$987,997.00 
Equity 
4
2022-03-22 
$78,811.00 
$2,087,936.00 
$2,009,125.00 
Equity 
3
2021-03-04 
$4,511,724.00 
$4,511,724.00 
$0.00 
Equity 
2
2020-08-18 
$2,089,079.00 
$8,025,000.00 
$5,935,921.00 
Equity 
1
2020-04-20 
$185,000.00 
$185,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AMZA 
 
ALI 
EXECUTIVE OFFICER
ARAS 
 
AZADIAN 
EXECUTIVE OFFICER, DIRECTOR
GIANCARLO 
 
DAVILA CHAR 
DIRECTOR
JANET 
 
GIEESSELMAN 
DIRECTOR
DR. ASSAD 
 
KAZEMINY 
DIRECTOR
BENJAMIN 
 
LEAVENWORTH 
DIRECTOR
EILEEN 
 
MCCORMACK 
DIRECTOR
JOHN 
 
MCVICAR 
DIRECTOR
LUCAS 
 
NOSIGLIA 
EXECUTIVE OFFICER
CHANDRAKANT 
 
PANCHAL 
DIRECTOR
DR. CHANDRAKANT 
 
PANCHAL 
DIRECTOR
SETU 
 
PUROHIT 
EXECUTIVE OFFICER, DIRECTOR
DAVE 
 
SOHI 
EXECUTIVE OFFICER
DAVENDER 
 
SOHI 
EXECUTIVE OFFICER
DAVID 
ALLAN 
WHITE 
DIRECTOR
FLAVIO 
 
ZACLIS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-17 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-06 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-22 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-04 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-18 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CANACCORD GENUITY CORP.
NONE